Compare Cannabis Stocks

Compare Cannabis stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., CGC, JAZZ, ABBV, HEXO) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CGC Canopy Growth	$1.13 -5.0%	$1.41	$0.77 ▼ $8.65	$207.77M	0.73	6.58 million shs	12.95 million shs
JAZZ Jazz Pharmaceuticals	$110.27 -2.0%	$108.32	$95.49 ▼ $148.06	$6.67B	0.32	831,492 shs	404,731 shs
ABBV AbbVie	$192.32 -1.4%	$187.01	$163.81 ▼ $218.66	$339.94B	0.48	6.31 million shs	4.99 million shs
HEXO HEXO	$0.71 +2.5%	$0.87	$0.66 ▼ $3.84	$31.24M	1.35	880,508 shs	305,500 shs
MO Altria Group	$57.79 -1.3%	$59.25	$47.53 ▼ $61.26	$97.36B	0.59	8.67 million shs	9.43 million shs
SMG Scotts Miracle-Gro	$69.29 -0.2%	$62.33	$45.61 ▼ $93.90	$4.00B	2.01	961,601 shs	692,150 shs
CURLF Curaleaf	$1.15 -5.7%	$0.87	$0.68 ▼ $4.45	$770.72M	0.62	514,188 shs	511,419 shs
GTBIF Green Thumb Industries	$6.56 +2.3%	$5.43	$4.63 ▼ $12.25	$1.39B	1.18	402,053 shs	536,565 shs
TCNNF Trulieve Cannabis	$4.58 -3.2%	$4.04	$3.02 ▼ $13.78	N/A	N/A	417,502 shs	593,733 shs

A Beginner's Guide to Investing in Cannabis

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CGC Canopy Growth	0.00%	-12.74%	-26.14%	+20.21%	-82.15%
JAZZ Jazz Pharmaceuticals	0.00%	+0.75%	-0.02%	+9.72%	+7.86%
ABBV AbbVie	0.00%	+1.49%	+0.03%	+9.96%	+14.38%
HEXO HEXO	0.00%	0.00%	0.00%	0.00%	0.00%
MO Altria Group	0.00%	-3.07%	-3.60%	+1.95%	+23.14%
SMG Scotts Miracle-Gro	0.00%	+1.09%	+8.71%	+35.57%	+13.00%
CURLF Curaleaf	0.00%	+37.48%	+39.50%	+43.23%	-69.82%
GTBIF Green Thumb Industries	0.00%	+19.27%	+30.94%	+30.42%	-41.95%
TCNNF Trulieve Cannabis	0.00%	+18.66%	+22.06%	+35.51%	-50.16%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CGC Canopy Growth	0.4105 of 5 stars	0.0	2.0	0.0	0.0	2.7	0.0	1.3
JAZZ Jazz Pharmaceuticals	4.834 of 5 stars	4.5	1.0	0.0	4.0	1.4	3.3	2.5
ABBV AbbVie	4.4985 of 5 stars	2.4	3.0	3.3	3.9	3.2	1.7	1.3
HEXO HEXO	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MO Altria Group	4.3826 of 5 stars	2.0	5.0	5.0	0.0	3.4	0.8	1.9
SMG Scotts Miracle-Gro	4.1303 of 5 stars	2.3	2.0	2.5	1.4	2.3	3.3	1.9
CURLF Curaleaf	2.2562 of 5 stars	3.5	2.0	0.0	0.0	2.3	0.0	1.3
GTBIF Green Thumb Industries	1.1429 of 5 stars	0.0	3.0	0.0	0.0	2.4	0.0	1.9
TCNNF Trulieve Cannabis	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CGC Canopy Growth	1.00	Sell	N/A	N/A
JAZZ Jazz Pharmaceuticals	2.92	Moderate Buy	$184.00	66.86% Upside
ABBV AbbVie	2.81	Moderate Buy	$211.29	9.86% Upside
HEXO HEXO	0.00	N/A	N/A	N/A
MO Altria Group	2.00	Hold	$56.75	-1.80% Downside
SMG Scotts Miracle-Gro	2.67	Moderate Buy	$68.17	-1.62% Downside
CURLF Curaleaf	3.00	Buy	$6.25	443.48% Upside
GTBIF Green Thumb Industries	4.00	Strong Buy	N/A	N/A
TCNNF Trulieve Cannabis	3.00	Buy	$14.50	216.59% Upside

Current Analyst Ratings Breakdown

Latest Cannabis Stocks Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/9/2025	MO Altria Group	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Underperform	$50.00
7/9/2025	SMG Scotts Miracle-Gro	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$72.00 ➝ $75.00
7/2/2025	MO Altria Group	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sell ➝ Neutral	$47.00 ➝ $59.00
6/11/2025	JAZZ Jazz Pharmaceuticals	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$202.00
6/11/2025	ABBV AbbVie	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold	$205.00
6/9/2025	ABBV AbbVie	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold	$204.00
6/9/2025	SMG Scotts Miracle-Gro	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$70.00 ➝ $71.00
6/6/2025	SMG Scotts Miracle-Gro	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$70.00 ➝ $75.00
6/6/2025	SMG Scotts Miracle-Gro	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$67.00 ➝ $72.00
6/3/2025	JAZZ Jazz Pharmaceuticals	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$202.00
5/30/2025	CGC Canopy Growth	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Underweight ➝ Underweight

(Data available from 7/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CGC Canopy Growth	$269.00M	0.77	N/A	N/A	$1.90 per share	0.59
JAZZ Jazz Pharmaceuticals	$4.07B	1.64	$30.38 per share	3.63	$67.72 per share	1.63
ABBV AbbVie	$56.33B	6.03	$14.92 per share	12.89	$1.90 per share	101.22
HEXO HEXO	$146.20M	0.21	N/A	N/A	$2.44 per share	0.29
MO Altria Group	$24.02B	4.05	$5.37 per share	10.76	($1.29) per share	-44.80
SMG Scotts Miracle-Gro	$3.55B	1.13	$3.74 per share	18.52	($6.87) per share	-10.09
CURLF Curaleaf	$1.34B	0.57	$0.20 per share	5.66	$1.51 per share	0.76
GTBIF Green Thumb Industries	$1.14B	1.22	$0.88 per share	7.44	$8.47 per share	0.77
TCNNF Trulieve Cannabis	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CGC Canopy Growth	-$429.86M	-$4.04	N/A	N/A	N/A	-195.76%	-88.54%	-40.78%	8/8/2025 (Estimated)
JAZZ Jazz Pharmaceuticals	$560.12M	$7.50	14.70	5.89	4.76	11.86%	26.62%	9.14%	7/30/2025 (Estimated)
ABBV AbbVie	$4.28B	$2.35	81.84	13.76	1.28	7.31%	412.03%	13.11%	7/31/2025 (Estimated)
HEXO HEXO	-$845.90M	-$5.21	N/A	N/A	N/A	-235.33%	-74.04%	-32.51%	N/A
MO Altria Group	$11.26B	$5.97	9.68	10.43	3.39	43.09%	-295.44%	25.48%	7/30/2025 (Estimated)
SMG Scotts Miracle-Gro	-$34.90M	$0.50	138.58	17.15	N/A	1.04%	-56.15%	5.61%	7/30/2025 (Estimated)
CURLF Curaleaf	-$215.42M	-$0.31	N/A	N/A	N/A	-17.37%	-14.12%	-4.40%	N/A
GTBIF Green Thumb Industries	$73.08M	$0.21	31.24	18.22	N/A	4.41%	2.82%	1.98%	8/4/2025 (Estimated)
TCNNF Trulieve Cannabis	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	8/4/2025 (Estimated)

Latest Cannabis Stocks Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/8/2025	Q1 2026	CGC Canopy Growth	-$0.10	N/A	N/A	N/A	$64.98 million	N/A
8/4/2025	N/A	GTBIF Green Thumb Industries	$0.04	N/A	N/A	N/A	$280.66 million	N/A
8/4/2025	N/A	TCNNF Trulieve Cannabis	-$0.0603	N/A	N/A	N/A	$303.04 million	N/A
7/30/2025	Q2 2025	JAZZ Jazz Pharmaceuticals	-$5.61	N/A	N/A	N/A	$1.05 billion	N/A
7/30/2025	Q2 2025	MO Altria Group	$1.37	N/A	N/A	N/A	$5.21 billion	N/A
7/30/2025	Q3 2025	SMG Scotts Miracle-Gro	$2.19	N/A	N/A	N/A	$1.23 billion	N/A
7/24/2025	Q2 2025	ABBV AbbVie	$3.24	N/A	N/A	N/A	$14.93 billion	N/A
5/30/2025	Q4 2025	CGC Canopy Growth	-$0.28	-$0.94	-$0.66	-$1.00	$71.84 million	$45.30 million
5/8/2025	Q1 2025	CURLF Curaleaf	-$0.07	-$0.07	N/A	-$0.08	N/A	N/A
5/7/2025	Q1 2025	GTBIF Green Thumb Industries	$0.05	$0.04	-$0.01	$0.04	$283.36 million	$279.54 million
5/6/2025	Q1 2025	JAZZ Jazz Pharmaceuticals	$4.65	$1.68	-$2.97	-$1.52	$984.16 million	$897.84 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CGC Canopy Growth	N/A	N/A	N/A	N/A	N/A
JAZZ Jazz Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
ABBV AbbVie	$6.56	3.41%	N/A	279.15%	53 Years
HEXO HEXO	N/A	N/A	N/A	N/A	N/A
MO Altria Group	$4.08	7.06%	N/A	68.34%	56 Years
SMG Scotts Miracle-Gro	$2.64	3.81%	N/A	528.00%	N/A
CURLF Curaleaf	N/A	N/A	N/A	N/A	N/A
GTBIF Green Thumb Industries	N/A	N/A	N/A	N/A	N/A
TCNNF Trulieve Cannabis	N/A	N/A	N/A	N/A	N/A

Latest Cannabis Stocks Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/20/2025	ABBV AbbVie	quarterly	$1.64	3.54%	7/15/2025	7/15/2025	8/15/2025
5/16/2025	MO Altria Group	quarterly	$1.02	6.9%	6/16/2025	6/16/2025	7/10/2025
4/21/2025	SMG Scotts Miracle-Gro	quarterly	$0.66	5.15%	5/23/2025	5/23/2025	6/6/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CGC Canopy Growth	0.62	3.12	2.10
JAZZ Jazz Pharmaceuticals	1.28	3.38	2.97
ABBV AbbVie	44.14	0.76	0.64
HEXO HEXO	0.01	0.41	0.24
MO Altria Group	N/A	0.57	0.47
SMG Scotts Miracle-Gro	N/A	1.71	0.94
CURLF Curaleaf	1.08	1.41	0.70
GTBIF Green Thumb Industries	N/A	2.38	1.55
TCNNF Trulieve Cannabis	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CGC Canopy Growth	3.33%
JAZZ Jazz Pharmaceuticals	89.14%
ABBV AbbVie	70.23%
HEXO HEXO	7.78%
MO Altria Group	57.41%
SMG Scotts Miracle-Gro	74.07%
CURLF Curaleaf	0.03%
GTBIF Green Thumb Industries	0.09%
TCNNF Trulieve Cannabis	N/A

Insider Ownership

Company	Insider Ownership
CGC Canopy Growth	1.30%
JAZZ Jazz Pharmaceuticals	4.30%
ABBV AbbVie	0.25%
HEXO HEXO	4.69%
MO Altria Group	0.08%
SMG Scotts Miracle-Gro	25.37%
CURLF Curaleaf	N/A
GTBIF Green Thumb Industries	9.40%
TCNNF Trulieve Cannabis	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CGC Canopy Growth	3,150	183.87 million	181.48 million	Optionable
JAZZ Jazz Pharmaceuticals	2,800	60.51 million	57.91 million	Optionable
ABBV AbbVie	55,000	1.77 billion	1.76 billion	Optionable
HEXO HEXO	1,277	44.00 million	41.93 million	Optionable
MO Altria Group	6,200	1.68 billion	1.68 billion	Optionable
SMG Scotts Miracle-Gro	6,200	57.72 million	43.07 million	Optionable
CURLF Curaleaf	5,519	670.19 million	N/A	Not Optionable
GTBIF Green Thumb Industries	4,800	211.71 million	191.81 million	Not Optionable
TCNNF Trulieve Cannabis	9,000	N/A	N/A	Not Optionable

Cannabis Stocks Headlines

Recent News About These Companies

Trulieve Partners with Redemption Cannabis to Launch Purpose Led ...

July 12 at 11:45 PM | morningstar.comM

Here are 2 Marijuana Stocks To Watch In A Down Sector

July 12 at 11:14 AM | marijuanastocks.comM

Trulieve Cannabis Corp. (TCNNF) - Yahoo Finance

July 11 at 10:52 PM | finance.yahoo.com

Trulieve Partners with Redemption Cannabis to Launch Purpose-Driven Products in West Virginia

July 11 at 12:07 PM | tipranks.com

Trulieve Partners with Redemption Cannabis to Launch Purpose Led Products in West Virginia

July 11 at 8:00 AM | prnewswire.com

Trulieve Cannabis Corp. to Hold Second Quarter 2025 Results Conference Call on August 6, 2025

July 9, 2025 | prnewswire.com

Best U.S. Cannabis Stocks to Track This Week for Growth and Momentum

July 8, 2025 | marijuanastocks.comM

Trulieve Cannabis (OTCMKTS:TCNNF) Trading Down 3.5% - Should You Sell?

July 3, 2025 | americanbankingnews.com

Trulieve Cannabis Corp Ordinary Shares (Sub Voting) TCNNF

July 2, 2025 | morningstar.comM

Trulieve Files Shelf Registration for Future Financing Flexibility

July 2, 2025 | theglobeandmail.com

Trulieve Announces Registration Statement Filing

June 30, 2025 | prnewswire.com

Marijuana Market Watch: Stocks to Track as the Industry Expands in 2025

June 28, 2025 | marijuanastocks.comM

Marijuana Stocks to Watch: Navigating Volatility With Smart Risk and Timing

June 26, 2025 | marijuanastocks.comM

Trulieve to Open Medical Cannabis Dispensary in Oakland Park, Florida

June 26, 2025 | prnewswire.com

Top Marijuana Stocks to Watch as U.S. Cannabis Industry Expands in 2025

June 21, 2025 | marijuanastocks.comM

3 Top Marijuana Stocks If You Plan To Make A Profit In The Cannabis Sector

June 16, 2025 | marijuanastocks.comM

Top Marijuana Stocks Poised for Growth This Week

June 10, 2025 | marijuanastocks.comM

Trulieve Cannabis to Participate in June 2025 Benzinga Conference

June 6, 2025 | tipranks.com

Trulieve Announces June 2025 Event Participation

June 6, 2025 | prnewswire.com

Trulieve Launches ‘Roll-Up for Justice’ Campaign to Support Cannabis Reform

June 2, 2025 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cannabis Stocks Company Descriptions

Canopy Growth NASDAQ:CGC

$1.13 -0.06 (-5.04%)

Closing price 07/11/2025 04:00 PM Eastern

Extended Trading

$1.16 +0.03 (+2.21%)

As of 07/11/2025 07:56 PM Eastern

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Jazz Pharmaceuticals NASDAQ:JAZZ

$110.27 -2.21 (-1.96%)

Closing price 07/11/2025 04:00 PM Eastern

Extended Trading

$110.37 +0.10 (+0.09%)

As of 07/11/2025 05:18 PM Eastern

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company offers Xywav for cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia; Xyrem to treat cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut and Dravet syndromes, or tuberous sclerosis complex; Zepzelca to treat metastatic small cell lung cancer, or with disease progression on or after platinum-based chemotherapy; Rylaze for acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Defitelio to treat severe hepatic veno-occlusive disease; and Vyxeos for newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Zepzelca for the treatment of patients with select relapsed/refractory solid tumors based on limited response in three solid tumor cohorts; JZP815, a pan-RAF kinase inhibitor that targets components of the mitogen-activated protein kinase; JZP898, a conditionally-activated interferon alpha molecule; Epidiolex to treat LGS, DS, and TSC; Suvecaltamide to treat parkinson's disease tremor; JZP150, a fatty acid amide hydrolase inhibitor program to treat post-traumatic stress disorder; and JZP441 to treat narcolepsy, IH, and other sleep disorders. The company has licensing and collaboration agreements with XL-protein GmbH to extend the plasma half-life of selected asparaginase product candidates; Redx Pharma plc for preclinical activities Ras/Raf/MAP kinase pathway program; and Autifony Therapeutics Limited on discovering and developing drug candidates targeting two different ion channel targets associated with neurological disorders. The company was incorporated in 2003 and is headquartered in Dublin, Ireland.

AbbVie NYSE:ABBV

$192.32 -2.68 (-1.37%)

Closing price 07/11/2025 03:59 PM Eastern

Extended Trading

$192.38 +0.06 (+0.03%)

As of 07/11/2025 07:50 PM Eastern

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

HEXO NYSE:HEXO

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.

Altria Group NYSE:MO

$57.79 -0.76 (-1.30%)

Closing price 07/11/2025 03:59 PM Eastern

Extended Trading

$57.90 +0.11 (+0.19%)

As of 07/11/2025 07:59 PM Eastern

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia.

Scotts Miracle-Gro NYSE:SMG

$69.29 -0.12 (-0.17%)

Closing price 07/11/2025 03:59 PM Eastern

Extended Trading

$68.98 -0.31 (-0.44%)

As of 07/11/2025 06:24 PM Eastern

The Scotts Miracle-Gro Company, together with its subsidiaries, manufactures, markets, and sells products for lawn, garden care, and indoor and hydroponic gardening in the United States and internationally. It operates through three segments: U.S. Consumer, Hawthorne, and Other. The company provides lawn care products, comprising lawn fertilizers, grass seed products, spreaders, and other durable products, as well as lawn-related weed, pest, and disease control products; and gardening and landscape products, which include water-soluble and continuous-release plant foods, potting mixes, garden soils, mulches and ground cover products, plant-related pest and disease control products, organic garden products, and live goods and seeding solutions. It offers hydroponic products that help users to grow plants, flowers, and vegetables using little or no soil; lighting systems and components for use in hydroponic and indoor gardening applications; insect, rodent, and weed control products for home areas; and non-selective weed killer products. The company sells its products under the Scotts, Turf Builder, EZ Seed, PatchMaster, Thick'R Lawn, GrubEx, EdgeGuard, Handy Green II, Miracle-Gro, LiquaFeed, Shake N Feed, Hyponex, Earthgro, Nature Scapes, Ortho, Miracle-Gro Performance Organics, Miracle-Gro Organic Choice, Whitney Farms, EcoScraps, Mother Earth, Botanicare, General Hydroponics, Cyco, Gavita, Agrolux, HydroLogic Purification System, Gro Pro, AeroGarden, Titan, Tomcat, Ortho Weed B Gon, Roundup, Groundclear, and Alchemist brands. It serves home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, and food and drug stores, as well as indoor gardening and hydroponic distributors, retailers, and growers. The Scotts Miracle-Gro Company was founded in 1868 and is headquartered in Marysville, Ohio.

Curaleaf OTCMKTS:CURLF

$1.15 -0.07 (-5.74%)

As of 07/11/2025 03:59 PM Eastern

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. The company is headquartered in New York, New York.

Green Thumb Industries OTCMKTS:GTBIF

$6.56 +0.15 (+2.34%)

As of 07/11/2025 03:59 PM Eastern

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

Trulieve Cannabis OTCMKTS:TCNNF

$4.58 -0.15 (-3.17%)

As of 07/11/2025 03:59 PM Eastern

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, creams, balms, salves, lotions, vaporizers, batteries, cartridge, concentrates, topicals, capsules, synringes, tinctures, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It also operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Cannabis Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest Cannabis Stocks Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest Cannabis Stocks Earnings

Compare Dividends

Latest Cannabis Stocks Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

Cannabis Stocks Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cannabis Stocks Company Descriptions

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools